Pivotal PK/PD study of PF530 in patients with multiple sclerosis

Trial Profile

Pivotal PK/PD study of PF530 in patients with multiple sclerosis

Planning
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2016

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Pfenex
  • Most Recent Events

    • 17 Mar 2016 New trial record
    • 10 Mar 2016 According to Pfenex media release, company is planning to initiate this trial in 2H2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top